{
    "organizations": [],
    "uuid": "439d58009ba68d106ccaf9b0a55cd31483272075",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-editas-medicine-reports-data-demon/brief-editas-medicine-reports-data-demonstrating-subretinal-injection-of-edit-101-well-tolerated-in-non-human-primates-idUSFWN1SP0VG",
    "ord_in_thread": 0,
    "title": "BRIEF-Editas Medicine Reports Data Demonstrating Subretinal Injection Of Edit-101 Well-Tolerated In Non-Human Primates",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Editas Medicine Inc:\n* EDITAS MEDICINE REPORTS DATA DEMONSTRATING SUBRETINAL INJECTION OF EDIT-101 WELL-TOLERATED IN NON-HUMAN PRIMATES\n* EDITAS MEDICINE INC - BOTH EDIT-101 AND VIR-067 WERE WELL TOLERATED IN ANIMALS TREATED WITH PROPHYLACTIC STEROIDS\n* EDITAS MEDICINE INC - EDITAS MEDICINE AIMS TO FILE AN INVESTIGATIONAL NEW DRUG (IND) APPLICATION FOR EDIT-101 BY MID-2018 Source text for Eikon: Further company coverage:\n ",
    "published": "2018-05-19T05:07:00.000+03:00",
    "crawled": "2018-05-19T15:17:42.016+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "editas",
        "medicine",
        "inc",
        "editas",
        "medicine",
        "report",
        "data",
        "demonstrating",
        "subretinal",
        "injection",
        "primate",
        "editas",
        "medicine",
        "inc",
        "well",
        "tolerated",
        "animal",
        "treated",
        "prophylactic",
        "steroid",
        "editas",
        "medicine",
        "inc",
        "editas",
        "medicine",
        "aim",
        "file",
        "investigational",
        "new",
        "drug",
        "ind",
        "application",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}